This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Novartis Technical Development Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Frédéric Zecri: Innovator in Pharmaceutical Compounds
Introduction
Frédéric Zecri is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. His work is characterized by a focus on creating effective solutions for various medical applications.
Latest Patents
Frédéric Zecri holds a patent for the invention titled "7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl) Compounds and Uses Thereof." This patent reflects his expertise in synthesizing novel chemical compounds that have potential therapeutic uses. He has been recognized for his innovative approach, which has led to the successful development of this compound.
Career Highlights
Currently, Frédéric Zecri is employed at Suzhou Novartis Technical Development Co., Ltd. His role at this esteemed company allows him to leverage his skills and knowledge in pharmaceutical development. His career is marked by a commitment to advancing medical science through innovative research and development.
Collaborations
Frédéric has collaborated with several talented individuals in his field, including Vincent Bordas and Jvan Brun. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise, ultimately leading to groundbreaking advancements in pharmaceutical compounds.
Conclusion
Frédéric Zecri is a distinguished inventor whose work in pharmaceutical compounds has made a significant impact in the industry. His innovative spirit and dedication to research continue to drive advancements in medical science.